Previous close | 8.45 |
Open | 8.30 |
Bid | 7.75 x 0 |
Ask | 8.10 x 0 |
Day's range | 7.90 - 8.30 |
52-week range | 7.60 - 10.60 |
Volume | |
Avg. volume | 0 |
Market cap | N/A |
Beta (5Y monthly) | N/A |
PE ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
Theravance Biopharma ( NASDAQ:TBPH ) First Quarter 2024 Results Key Financial Results Revenue: US$14.5m (up 39% from 1Q...
Theravance's (TBPH) first-quarter 2024 earnings beat estimates while revenues meet the same.
Theravance Bio (TBPH) delivered earnings and revenue surprises of 52.63% and 0.25%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?